Differential effects of single and repeated ketamine administration on dopamine, serotonin and GABA transmission in rat medial prefrontal cortex. (Q48683925)

From Wikidata

Jump to navigation Jump to search

scientific article published in June 1997

Language	Label	Description	Also known as
English	Differential effects of single and repeated ketamine administration on dopamine, serotonin and GABA transmission in rat medial prefrontal cortex.	scientific article published in June 1997

Statements

scholarly article

1 reference

Europe PubMed Central

14 February 2018

http://europepmc.org/abstract/MED/9221938

Differential effects of single and repeated ketamine administration on dopamine, serotonin and GABA transmission in rat medial prefrontal cortex. (English)

1 reference

Europe PubMed Central

14 February 2018

http://europepmc.org/abstract/MED/9221938

0 references

0 references

William T O'Connor

3

1 reference

Europe PubMed Central

14 February 2018

http://europepmc.org/abstract/MED/9221938

author name string

Lindefors N

1

1 reference

Europe PubMed Central

14 February 2018

http://europepmc.org/abstract/MED/9221938

Barati S

2

1 reference

Europe PubMed Central

14 February 2018

http://europepmc.org/abstract/MED/9221938

language of work or name

0 references

publication date

1 June 1997

1 reference

Europe PubMed Central

14 February 2018

http://europepmc.org/abstract/MED/9221938

1 reference

Europe PubMed Central

14 February 2018

http://europepmc.org/abstract/MED/9221938

759

1 reference

Europe PubMed Central

14 February 2018

http://europepmc.org/abstract/MED/9221938

2

1 reference

Europe PubMed Central

14 February 2018

http://europepmc.org/abstract/MED/9221938

205-212

1 reference

Europe PubMed Central

14 February 2018

http://europepmc.org/abstract/MED/9221938

Selective alterations in gene expression for NMDA receptor subunits in prefrontal cortex of schizophrenics

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2900255-2

7 January 2021

Dysfunction in a prefrontal substrate of sustained attention in schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2900255-2

7 January 2021

Frontal cortical and left temporal glutamatergic dysfunction in schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2900255-2

7 January 2021

Phencyclidine analogues inhibit NMDA-stimulated [3H]GABA release from cultured cortex neurons.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2900255-2

7 January 2021

Effect of phencyclidine on dopamine release in the rat prefrontal cortex; an in vivo microdialysis study.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2900255-2

7 January 2021

Recent advances in the phencyclidine model of schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2900255-2

7 January 2021

The dopamine hypothesis of schizophrenia: limbic interactions with serotonin and norepinephrine

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2900255-2

7 January 2021

Dizocilpine (MK-801) elicits a tetrodotoxin-sensitive increase in extracellular release of dopamine in rat medial frontal cortex.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2900255-2

7 January 2021

Fast HPLC Estimation of ?-Aminobutyric Acid in Microdialysis Perfusates: Effect of Nipecotic and 3-Mercaptopropionic Acids

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2900255-2

7 January 2021

Low cerebrospinal fluid glutamate in schizophrenic patients and a new hypothesis on schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2900255-2

7 January 2021

Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans. Psychotomimetic, perceptual, cognitive, and neuroendocrine responses

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2900255-2

7 January 2021

Behavioural, pharmacological and biochemical effects of acute and chronic administration of ketamine in the rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2900255-2

7 January 2021

MK-801 decreases striatal and cortical GAD65 mRNA levels

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2900255-2

7 January 2021

Dopaminergic mechanisms in idiopathic and drug-induced psychoses

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2900255-2

7 January 2021

The receptor antagonist MK-801 induces increases in dopamine and serotonin metabolism in several brain regions of rats

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2900255-2

7 January 2021

The behavioural effects of MK-801 in rats: involvement of dopaminergic, serotonergic and noradrenergic systems

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2900255-2

7 January 2021

Dopamine D1 and D2 receptor antagonism differentially modulates stimulation of striatal neurotransmitter levels by N-methyl-D-aspartic acid.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2900255-2

7 January 2021

Excitatory amino acid antagonists and memory: effect of drugs acting at N-methyl-D-aspartate receptors in learning and memory tasks

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2900255-2

7 January 2021

Schizophrenics show spatial working memory deficits.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2900255-2

7 January 2021

Dopaminergic and glutamatergic blocking drugs differentially regulate glutamic acid decarboxylase mRNA in mouse brain

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2900255-2

7 January 2021

Abnormally high neuronal density in the schizophrenic cortex. A morphometric analysis of prefrontal area 9 and occipital area 17.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2900255-2

7 January 2021

Evidence of glutamatergic deficiency in schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2900255-2

7 January 2021

Properties of the optical isomers and metabolites of ketamine on the high affinity transport and catabolism of monoamines

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2900255-2

7 January 2021

Cognitive impairment in schizophrenia.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2900255-2

7 January 2021

An N-methylaspartate receptor-mediated synapse in rat cerebral cortex: a site of action of ketamine?

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2900255-2

7 January 2021

Excitatory amino acids: implications for psychiatric disorders research.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2900255-2

7 January 2021

Abnormal excitatory neurotransmitter metabolism in schizophrenic brains

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2900255-2

7 January 2021

NMDA receptor antagonists impair prefrontal cortex function as assessed via spatial delayed alternation performance in rats: modulation by dopamine.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2900255-2

7 January 2021

MK-801 elevates the extracellular concentration of dopamine in the rat prefrontal cortex and increases the density of striatal dopamine D1 receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2900255-2

7 January 2021

Physiological dysfunction of dorsolateral prefrontal cortex in schizophrenia. III. A new cohort and evidence for a monoaminergic mechanism.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2900255-2

7 January 2021

Modulation of memory fields by dopamine D1 receptors in prefrontal cortex.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2900255-2

7 January 2021

Postsynaptic supersensitivity after 6-hydroxy-dopamine induced degeneration of the nigro-striatal dopamine system.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2900255-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0006-8993(97)00255-2

1 reference

Europe PubMed Central

14 February 2018

http://europepmc.org/abstract/MED/9221938

1 reference

Europe PubMed Central

14 February 2018

http://europepmc.org/abstract/MED/9221938

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q48683925&oldid=1385567459"